DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Funds / Oncology Investors of Texas Costim, LLC
Oncology Investors of Texas Costim, LLC
Amounts, each with its basis
- Vintage
- 2013basis: form d first sale
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- $1.7Mwhat may be sold, not what was raised; joined by exact issuer name, corroborated by the general partner the adviser swears for this fund, the issuer filing from the adviser's state, not sworn by the adviser (confidence 0.70); file 021-202346
- Form D sold
- $1.7Mas of the filing of Sep 5, 2013, 7 investors
- First sale
- Aug 28, 2013
- Reported GAV
- $947,009on the Form ADV filed Jun 26, 2024; the fund's assets, never its size or dry powder
- Owners (ADV)
- 8
- Reported on ADV
- Apr 1, 2014 to Jun 26, 2024
Fundraising evidence
Closed to new capital
Form D filed or amended 2013-09-05: the stated $1.7M offering reported fully sold (fr-1)
evidence dated Sep 5, 2013. A Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Lifecycle
Harvest
vintage over 7 years, still reported
age years: 13first sale: 2013-08-28vintage year: $2,013adv gav as of: 2024-06-26vintage basis: form_d_first_saleform d sold usd: $1.7Mform d offering usd: $1.7Mform d latest filed at: 2013-09-05
The fund's own reporting through time
23 Form ADV filings
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Apr 1, 2014 | Venture Capital Fund | $6.3M | 8 | $100,000 | 0% | no | |
| Apr 1, 2015 | Venture Capital Fund | $7.3M | 8 | $100,000 | 0% | no | |
| Nov 23, 2015 | Venture Capital Fund | $3.8M | 8 | $100,000 | 0% | no | |
| Nov 24, 2015 | Venture Capital Fund | $3.8M | 8 | $100,000 | 0% | no | |
| Nov 24, 2015 | Venture Capital Fund | $3.8M | 8 | $100,000 | 0% | no | |
| Mar 29, 2016 | Venture Capital Fund | $4.3M | 8 | $100,000 | 0% | no | |
| Feb 7, 2017 | Venture Capital Fund | $4.3M | 8 | $100,000 | 0% | no | |
| Mar 30, 2017 | Venture Capital Fund | $3.3M | 7 | $100,000 | 0% | no | |
| Mar 30, 2018 | Venture Capital Fund | $3.0M | 7 | $100,000 | 0% | yes | |
| Jul 6, 2018 | Venture Capital Fund | $3.0M | 7 | $100,000 | 0% | yes | |
| Mar 28, 2019 | Venture Capital Fund | $3.0M | 7 | $100,000 | 0% | yes | |
| Jul 16, 2019 | Venture Capital Fund | $3.0M | 7 | $100,000 | 0% | yes | |
| Mar 30, 2020 | Venture Capital Fund | $2.9M | 7 | $100,000 | 0% | yes | |
| Apr 21, 2020 | Venture Capital Fund | $2.9M | 7 | $100,000 | 0% | yes | |
| Mar 29, 2021 | Venture Capital Fund | $2.9M | 7 | $100,000 | 0% | yes | |
| Mar 23, 2022 | Venture Capital Fund | $2.9M | 8 | $100,000 | 0% | yes | |
| Nov 17, 2022 | Venture Capital Fund | $2.9M | 8 | $100,000 | 0% | yes | |
| Mar 30, 2023 | Venture Capital Fund | $2.8M | 8 | $100,000 | 0% | yes | |
| Oct 30, 2023 | Venture Capital Fund | $2.8M | 8 | $100,000 | 0% | yes | |
| Mar 28, 2024 | Venture Capital Fund | $947,009 | 8 | $100,000 | 0% | yes | |
| Jun 6, 2024 | Venture Capital Fund | $947,009 | 8 | $100,000 | 0% | yes | |
| Jun 6, 2024 | Venture Capital Fund | $947,009 | 8 | $100,000 | 0% | yes | |
| Jun 26, 2024 | Venture Capital Fund | $947,009 | 8 | $100,000 | 0% | yes |
Principals and agents
6 principals on Form D, 0 placement agents
- ScienceSeed, LLC Promoter
- Bronson Crouch Director
- MPM Asset Management LLC Promoter
- Ansbert Gadicke Director
- Oncology Investors of Texas GP LLC Promoter
- Elizabeth Stoner Director
Limited partners and their reported performance
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
2 events
- Apr 1, 2014Oncology Investors of Texas Costim, LLC first reported on Form ADV by MPM Asset Management LLC (Venture Capital Fund), GAV $6,281,553Fund first reported on Form ADV Fact SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Sep 5, 2013Oncology Investors of Texas CoStim, LLC filed Form D: $1,732,333 sold of $1,732,333, Venture Capital FundForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
16 observations
Every observation on this vehicle
- Entity type: Limited Liability Company Sep 5, 2013 Fact SEC EDGAR Form D data sets (quarterly)
- Form D fund type: Venture Capital Fund Sep 5, 2013 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Pooled Investment Fund Sep 5, 2013 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Sep 5, 2013 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Sep 5, 2013 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: withinFiveYears Sep 5, 2013 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Sep 5, 2013 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $1.7M Sep 5, 2013 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $1.7M Sep 5, 2013 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06, 3C, 3C.7 Sep 5, 2013 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2013-08-28 Sep 5, 2013 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 7 Sep 5, 2013 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Sep 5, 2013 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: pooled Sep 5, 2013 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 200 CLARENDON STREET, 54TH FLOOR, BOSTON, MA, 02116 Sep 5, 2013 Fact SEC EDGAR Form D data sets (quarterly)
- Year of incorporation: 2013 Sep 5, 2013 Fact SEC EDGAR Form D data sets (quarterly)